Open AccessEntecavir administration to pregnant Japanese woman with chronic hepatitis B and hepatocellular carcinoma: A case report
Author(s) -
Kakiuchi Toshihiko,
Takahashi Hirokazu,
Iwane Shinji,
Koji Azusa,
Matsuo Muneaki
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3896
Subject(s) - entecavir , medicine , hepatocellular carcinoma , pregnancy , abortion , chronic hepatitis , gastroenterology , administration (probate law) , obstetrics , gynecology , virology , virus , lamivudine , biology , genetics , political science , law
Women taking entecavir hydrate (ETV) may not need to consider abortion in the event of an unexpected pregnancy. If a woman with renal dysfunction and taking ETV for chronic hepatitis B becomes pregnant, continuous use of ETV may also be tolerated.